No abstract available
MeSH terms
-
Androgen Antagonists / therapeutic use
-
Cohort Studies
-
Humans
-
Male
-
Prospective Studies
-
Prostate-Specific Antigen / blood*
-
Prostatic Neoplasms / blood
-
Prostatic Neoplasms / mortality*
-
Prostatic Neoplasms / radiotherapy*
-
Radiotherapy Dosage
-
Radiotherapy, Conformal
-
Salvage Therapy
-
Survival Rate
-
Time Factors
-
Treatment Failure
Substances
-
Androgen Antagonists
-
Prostate-Specific Antigen